Zargis Cardioscan 'The Intelligent Stethoscope' Now Available on Amazon.com
December 14 2009 - 9:35AM
PR Newswire (US)
STAMFORD, Conn., Dec. 14 /PRNewswire/ -- Zargis Medical Corp., a
majority-owned subsidiary of Speedus Corp. (NASDAQ:SPDE) and a
spin-off from Siemens Corporate Research (NYSE:SI) announced today
that it has begun selling its award-winning Zargis Cardioscan(TM)
system on Amazon.com, America's largest online retailer. Cardioscan
and its accompanying Bluetooth®-enabled electronic stethoscope were
jointly named Popular Science magazine's "2009 Innovation of the
Year." Cardioscan is the world's first FDA-cleared medical device
to identify and classify suspected systolic and diastolic heart
murmurs and was described as "The Intelligent Stethoscope" by The
Wall Street Journal when it was recognized with a Wall Street
Journal Technology Innovation Award. Cardioscan, along with the
accompanying stethoscope, are currently for sale on Amazon.com at a
special holiday price with free shipping. Orders placed by December
21st can be delivered by Christmas day. Zargis selected Amazon.com
because of Amazon's commitment to delivering the best possible
shopping experience and the online retailer's "A-to-Z guarantee
program", which provides Amazon.com customers with an added level
of confidence when making purchases. About Zargis Medical Corp.
Zargis Medical Corp. develops advanced diagnostic decision support
products and services for primary care physicians, pediatricians,
cardiologists and other healthcare professionals. Zargis was formed
in 2001 when Siemens Corporate Research, a division of Siemens AG
(NYSE:SI), and Speedus Corp. (NASDAQ:SPDE) co-invested to develop
and market an advanced acoustic technology designed to detect heart
abnormalities identified through analysis of heart sounds. For
additional information about Zargis or Speedus Corp., contact Peter
Hodge at 888.773.3669 (ext. 23) or , or visit the following Web
sites: http://www.zargis.com/ and http://www.speedus.com/.
Statements contained herein that are not historical facts,
including but not limited to statements about the Company's
product, corporate identity and focus, may be forward-looking
statements that are subject to a variety of risks and
uncertainties. There are a number of important factors that could
cause actual results to differ materially from those expressed in
any forward-looking statements made by the Company, including, but
not limited to, the continuing development of the Company's sales,
marketing and support efforts. DATASOURCE: Zargis Medical Corp.
CONTACT: Peter Hodge, +1-888-773-3669 (ext. 23) or Web Site:
http://www.zargis.com/
Copyright
Speedus (CE) (USOTC:SPDE)
Historical Stock Chart
From Sep 2024 to Oct 2024
Speedus (CE) (USOTC:SPDE)
Historical Stock Chart
From Oct 2023 to Oct 2024